Human genome epidemiology : building the evidence for using genetic information to improve health and prevent disease

=001  20061=003  WaSeSS=005  20100709134437.0=006  m        d=007  cr  n=008  090505s2010    enka    sb    001 0 eng d=010  ##$a2009018899=016  7\$a101504140 $2DNLM=020  ##$a0195398440 (cloth : alk. paper)=020  ##$a9780195398441 (cloth : alk. paper)=035  ##$a(WaSeSS)ssib004877762=035  ##$b25810406=040  ##$aDNLM/DLC $cDLC $dNLM $dC#P $dYDXCP $dVAM $dDLC $dWaSeSS=041  0#$aeng=042  ##$apcc=082  00$a616 $222=245  00$aHuman genome epidemiology $h[electronic resource] : $bbuilding the evidence for using genetic information to improve health and prevent disease / $cedited by Muin J. Khoury ... [et al.].=250  ##$a2nd ed.=260  ##$aOxford ; $aNew York : $bOxford University Press, $c2010=504  ##$aIncludes bibliographical references and index.=505  0#$aHuman genome epidemiology: the road map revisited -- Principles of analysis of germline genetics -- The public health genomics enterprise -- Navigating the evolving knowledge of human genetic variation in health and disease -- The global emergence of epidemiological biobanks: opportunities and challenges -- Case-control and cohort studies in the age of genome-wide associations -- The emergence of networks in human genome epidemiology: challenges and opportunities -- Design and analysis issues in genome-wide association studies -- The challenge of assessing complex gene-environment and gene-gene interactions -- STrengthening the REporting of genetic association studies (STREGA)-an extension of the STROBE statement -- Integration of the evidence on gene-disease associations: methods of HuGE reviews -- Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases -- Colorectal cancer -- Childhood leukemias -- Bladder cancer -- Type 2 diabetes -- Osteoporosis -- Preterm birth -- Coronary heart disease -- Schizophrenia -- Mendelian randomization: the contribution of genetic epidemiology to elucidating environmentally modifiable causes of disease -- Evaluation of predictive genetic tests for common diseases: bridging epidemiological, clinical, and public health measures -- The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group -- Rapid, evidence-based reviews of genetic tests -- Role of social and behavioral research in assessing the utility of genetic information -- Assessing the evidence for clinical utility in newborn screening -- The role of epidemiology in assessing the potential clinical impact of pharmacogenomics -- The human epigenome and cancer -- The use of family history in public health practice: the epidemiologic view -- Cytochrome P450 testing in the treatment of depression -- A rapid-ACCE review of CYP2CP and VKORC1 allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding -- Hereditary hemochromatosis: population screening for gene mutations.=506  ##$aAccess limited to La Trobe staff and students.=509  ##$aSerials Solutions eBook record.=650  #0$aGenetic disorders $xEpidemiology.=650  #0$aGenomics.=650  #0$aMedical genetics $xMethodology.=650  12$aGenetics, Medical $xmethods.=650  22$aGenetic Diseases, Inborn $xepidemiology.=650  22$aGenetic Predisposition to Disease $xepidemiology.=650  22$aGenetic Testing.=650  22$aGenome, Human.=650  22$aGenomics.=655  #0$aElectronic books.=700  1#$aKhoury, Muin J.=710  2#$aOxford Scholarship Online Public Health and Epidemiology.=LDR  03842nam a22004814a 4500